Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Covid 19 Infection
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
PRIMARY OBJECTIVES: To examine the feasibility and acceptability of implementing an interdisciplinary goal-setting clinical group program focused on domains of physical, psychological, and spiritual wellness for survivors of cancer at University of California San Francisco (UCSF). To determine preli...
PRIMARY OBJECTIVES: To examine the feasibility and acceptability of implementing an interdisciplinary goal-setting clinical group program focused on domains of physical, psychological, and spiritual wellness for survivors of cancer at University of California San Francisco (UCSF). To determine preliminary efficacy of the Survivorship Wellness intervention in regards to: Increasing knowledge of and perceived confidence in execution of health behavior changes in domains of physical, emotional, and spiritual wellness for survivors of cancer. Increasing quality of life. Reducing symptoms of depression and anxiety. Increasing physical activity. To assess differences in patient wellbeing and in the impact of the Survivorship Wellness program during the period of COVID-19 and telehealth classes. OUTLINE: Patients complete surveys over 5-10 minutes at baseline (i.e. before participating in the program), and at 9 and 15 weeks follow up on the impact of COVID-19 on survivorship. Patients also complete a survey assessing how patients rate telehealth classes in the Survivorship Wellness program.
Tracking Information
- NCT #
- NCT04630015
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Margaret Chesney, MD University of California, San Francisco